| Product Code: ETC067189 | Publication Date: Aug 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Vietnam Liquid Biopsy Market was estimated at USD 691 Million in 2025 and is projected to reach USD 981 Million by 2032, growing at a CAGR of 5.1% from 2026 to 2032. This growth trajectory reflects a critical shift in cancer diagnostics, as healthcare providers increasingly adopt liquid biopsy techniques for their non-invasive advantages. Factors contributing to this momentum include a rising cancer incidence and an urgent need for timely and precise treatment options that resonate within Vietnam's healthcare landscape.
This graph highlights how the Vietnam Liquid Biopsy Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 3.6% | Expansion of manufacturing activities |
| 2022 | 2.8% | Growing renewable energy integration projects |
| 2023 | 8.2% | Expansion of commercial construction activities |
| 2024 | 5.6% | Growing urbanization and commercial development |
| 2025 | 6.3% | Growing renewable energy integration projects |
| 2026 | 8.4% | Increasing adoption of advanced technologies |
| 2027 | 7.2% | Rising electricity demand across industries |
| 2028 | 6.6% | Expansion of manufacturing activities |
| 2029 | 6.4% | Rising electricity demand across industries |
| 2030 | 6.0% | Rapid growth in telecom and data center sectors |
| 2031 | 5.7% | Growing urbanization and commercial development |
| 2032 | 5.4% | Expansion of manufacturing activities |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The Vietnam Liquid Biopsy market has recently gained significant momentum as a vital tool in oncology, contrasting with traditional methods that often require invasive procedures. As awareness about early cancer detection grows, liquid biopsies are emerging as a preferred choice among both patients and healthcare providers.
Looking forward, the market is poised for continued expansion, spurred by advancements in genomic technologies and supportive government initiatives. This evolution promises not only to enhance diagnostic capabilities but also to facilitate personalized treatment strategies, thereby improving patient outcomes across the country.
Despite the market's growth, certain restraints pose challenges. Liquid biopsy technologies face hurdles related to the sensitivity and specificity required for accurate cancer biomarker detection. The need for standardized testing protocols across healthcare facilities is crucial for achieving reliable outcomes. Additionally, integrating these technologies into existing clinical practices may necessitate revisions to current medical workflows and reimbursement frameworks, which must be addressed to fully unlock the potential of liquid biopsy.
Emerging trends indicate a significant pivot towards personalized medicine, where liquid biopsy plays an instrumental role in tailoring treatments based on an individual’s genetic makeup. Moreover, there is a growing emphasis on developing more advanced liquid biopsy technologies that can not only identify biomarkers but also offer insights into tumor behavior and treatment resistance. This approach aligns with the broader shift in oncology towards precision medicine, wherein treatments are customized to the patient's unique cancer profile.
Opportunities abound in the Vietnam Liquid Biopsy market, especially in enhancing research and development efforts that focus on novel biomarker discovery. Additionally, the establishment of specialized oncology centers offers a fertile ground for liquid biopsy services to flourish. Investing in educational initiatives to raise awareness among healthcare professionals and patients about the benefits and applications of liquid biopsy will further bolster market penetration and acceptance.
The Vietnamese government is actively supporting the advancement of cancer care through policies aimed at improving access to innovative diagnostics. By investing in oncology research and encouraging collaborations between public and private sectors, the government is fostering an environment conducive to the growth of the liquid biopsy market. Initiatives that focus on enhancing healthcare infrastructure and increasing funding for cancer research play a pivotal role in shaping the future of oncology diagnostics in Vietnam.
Looking ahead to 2026-2032, the Vietnam Liquid Biopsy market is set to evolve dramatically. The integration of artificial intelligence and machine learning in analysis could streamline processes and enhance diagnostic accuracy. Furthermore, as the demand for personalized treatment continues to rise, liquid biopsy will likely become a standard component of cancer management protocols, ultimately transforming patient care in the region.
Recent developments indicate a robust push for innovation within the liquid biopsy sector. New partnerships are emerging between healthcare providers and biotech firms focused on enhancing the capabilities and reliability of liquid biopsy technologies. Additionally, significant strides in regulatory approvals are paving the way for more comprehensive liquid biopsy tests to enter the market, expanding the diagnostic toolkit available to oncologists.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Liquid Biopsy Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Liquid Biopsy Market Revenues & Volume, 2022 & 2032F |
3.3 Vietnam Liquid Biopsy Market - Industry Life Cycle |
3.4 Vietnam Liquid Biopsy Market - Porter's Five Forces |
3.5 Vietnam Liquid Biopsy Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Vietnam Liquid Biopsy Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Vietnam Liquid Biopsy Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Vietnam Liquid Biopsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Vietnam Liquid Biopsy Market Trends |
6 Vietnam Liquid Biopsy Market, By Types |
6.1 Vietnam Liquid Biopsy Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Liquid Biopsy Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 Vietnam Liquid Biopsy Market Revenues & Volume, By Handheld Instruments, 2022-2032F |
6.1.4 Vietnam Liquid Biopsy Market Revenues & Volume, By Inflation Devices, 2022-2032F |
6.1.5 Vietnam Liquid Biopsy Market Revenues & Volume, By Guiding Devices, 2022-2032F |
6.1.6 Vietnam Liquid Biopsy Market Revenues & Volume, By Electrosurgical & Electrocautery Instruments, 2022-2032F |
6.1.7 Vietnam Liquid Biopsy Market Revenues & Volume, By Others, 2022-2032F |
6.2 Vietnam Liquid Biopsy Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Liquid Biopsy Market Revenues & Volume, By Clinical Application, 2022-2032F |
6.2.3 Vietnam Liquid Biopsy Market Revenues & Volume, By Non-clinical Application, 2022-2032F |
6.3 Vietnam Liquid Biopsy Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Liquid Biopsy Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.3 Vietnam Liquid Biopsy Market Revenues & Volume, By Academic & Research Centers, 2022-2032F |
6.3.4 Vietnam Liquid Biopsy Market Revenues & Volume, By Others, 2022-2032F |
7 Vietnam Liquid Biopsy Market Import-Export Trade Statistics |
7.1 Vietnam Liquid Biopsy Market Export to Major Countries |
7.2 Vietnam Liquid Biopsy Market Imports from Major Countries |
8 Vietnam Liquid Biopsy Market Key Performance Indicators |
9 Vietnam Liquid Biopsy Market - Opportunity Assessment |
9.1 Vietnam Liquid Biopsy Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Vietnam Liquid Biopsy Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Vietnam Liquid Biopsy Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Vietnam Liquid Biopsy Market - Competitive Landscape |
10.1 Vietnam Liquid Biopsy Market Revenue Share, By Companies, 2025 |
10.2 Vietnam Liquid Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here